• Alker AP, Mwapasa V & Meshnick SR (2004) Rapid real-time PCR genotyping of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum. Antimicrobial Agents and Chemotherapy 48, 29242929.
  • Alker AP, Mwapasa V, Purfield A et al. (2005) Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrobial Agents and Chemotherapy 49, 39193921.
  • Bousema T, Drakeley C, Gesase S et al. (2010) Identification of hot spots of malaria transmission for targeted malaria control. Journal of Infectious Diseases 201, 17641774.
  • Desai M, ter Kuile FO, Nosten F et al. (2007) Epidemiology and burden of malaria in pregnancy. Lancet Infectious Diseases 7, 93104.
  • Eisele TP, Larsen DA, Anglewica PA et al. (2012) Malaria prevention in pregnancy, birthweight, and neonatal mortality; a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infectious Diseases pii: S1473-3099(12)70222-0. doi: 10.1016/S1473-3099(12)70222-0 [Epub ahead of print].
  • Harrington WE, Mutabingwa TK, Muehlenbachs A et al. (2009) Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proceedings of the National Academy of Sciences, USA 106, 90279032.
  • Harrington WE, Mutabingwa TK, Kabyemela E, Fried M & Duffy PE (2011) Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clinical Infectious Diseases 53, 224230.
  • ter Kuile FO, van Eijk AM & Filler SJ (2007) Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. Journal of the American Medical Association 297, 26032616.
  • Luntamo M, Kulmala T, Mbewe B, Cheung YB, Maleta K & Ashorn P (2010) Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial. American Journal of Tropical Medicine and Hygiene 83, 12121220.
  • Luntamo M, Rantala A-M, Meshnick S et al. (2012) The effect of monthly sulfadoxine-pyrimethamine, alone or with azithromycin, on PCR-diagnosed malaria at delivery: a randomized controlled trial. PLoS ONE 7, e41123.
  • Mockenhaupt FP, Bedu-Addo G, Eggelte TA et al. (2008) Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. Journal of Infectious Diseases 198, 545549.
  • Rantala AM, Taylor SM & Trottman PA (2010) Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malaria Journal 9, 269.
  • Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW & Udhayakumar V (2010) Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malaria Journal 9, 247.
  • Taylor SM, Antonia A, Feng G et al. (2012) Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study. Infection, Genetics and Evolution 12, 282290.
  • Umbers AJ, Aitken EH & Rogerson SJ (2011) Malaria in pregnancy: small babies, big problem. Trends in Parasitology 27, 168175.
  • WHO (2012). Evidence Review Group: Intermittent Preventive Treatment of malaria in pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP). WHO, Geneva, 9–11 July 2012. Found at: